LIMNNasdaq CM

Liminatus Pharma, Inc.

4.61−1.28%1d

Data as of Aug 25, 2026 · end-of-day snapshot

Volume signal tier
Alert levelBaseline

Tier and alert level are a summary. Unlock LIMN to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.

−29.08%, downReturn · 1w
+4375.73%, upReturn · 1m
+2461.11%, upReturn · 3m
+35.59%, upReturn · 1y
−49.89%, well below its 52-week highvs 52-week high
Technicals

Technical readings

The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.

Automated read

Price is trading above its key moving averages and momentum readings are contained: the mid-term picture reads as an orderly uptrend. RSI is currently 62.

RSI (14)61.71, favorable readingUpper-neutral
MACD / signal1.36 / 1.35, favorable readingAbove signal line
SMA 501.39, favorable readingPrice above
SMA 2000.73, favorable readingPrice above
EMA 203.84, favorable readingPrice above
ADX (14)50.02Trending
+DI / −DI51.31 / 21.38, favorable reading+DI leading
ATR (14)1.18, flagged reading25.6% of price — elevated daily swings
Stochastic %K49.58Mid-range
Bollinger bands (20)-2.78 – 9.36Inside bands
ROC (10)-17.68, caution readingNegative over 10 sessions
Trend / momentum impulseMixedTrend and momentum disagree

Readings as of Aug 25, 2026 · end-of-day snapshot

Full analysis

What unlocking LIMN reveals

Sample preview: figures are illustrative.

Company & theme write-up

Signal history

AI narrative

Catalysts & risks

Accumulation read

Unlock LIMN: full analysis
Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get LIMN + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
$9.90one-time Unlock LIMN